Global Age-Related Hearing Loss 麻豆原创 Research Report 2023

Publication ID:

PB510231701

Publication Date:

October 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Age-related Hearing Loss (AHL), also known as presbycusis, is a progressive, irreversible and symmetrical bilateral neurosensory hearing loss ensuing from the degeneration of the cochlea, wherein the sound-induced vibrations are shown by the sensory hair cells into the electrical signals within the cochlear neurons that further aid in relaying information to the brain region.
The global Age-Related Hearing Loss market is projected to reach US$ 3557.7 million in 2029, increasing from US$ 2550 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Age-Related Hearing Loss market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Age-Related Hearing Loss market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Advanced Bionics
Cochlear
MED-EL GmbH
Nurotron Biotechnology
Oticon Medical
Medtronic
Envoy Medical
Sonova
Audina Hearing Instruments
RION
Decibel Therapeutics
Frequency Therapeutics
Pipeline Therapeutics
Segment by Type
Devices
Drugs
Segment by Application
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Age-Related Hearing Loss report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Age-Related Hearing Loss 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Devices
1.2.3 Drugs
1.3 麻豆原创 by Application
1.3.1 Global Age-Related Hearing Loss 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age-Related Hearing Loss 麻豆原创 Perspective (2018-2029)
2.2 Age-Related Hearing Loss Growth Trends by Region
2.2.1 Global Age-Related Hearing Loss 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Age-Related Hearing Loss Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Age-Related Hearing Loss Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Age-Related Hearing Loss 麻豆原创 Dynamics
2.3.1 Age-Related Hearing Loss Industry Trends
2.3.2 Age-Related Hearing Loss 麻豆原创 Drivers
2.3.3 Age-Related Hearing Loss 麻豆原创 Challenges
2.3.4 Age-Related Hearing Loss 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-Related Hearing Loss Players by Revenue
3.1.1 Global Top Age-Related Hearing Loss Players by Revenue (2018-2023)
3.1.2 Global Age-Related Hearing Loss Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Age-Related Hearing Loss 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age-Related Hearing Loss Revenue
3.4 Global Age-Related Hearing Loss 麻豆原创 Concentration Ratio
3.4.1 Global Age-Related Hearing Loss 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-Related Hearing Loss Revenue in 2022
3.5 Age-Related Hearing Loss Key Players Head office and Area Served
3.6 Key Players Age-Related Hearing Loss Product Solution and Service
3.7 Date of Enter into Age-Related Hearing Loss 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-Related Hearing Loss Breakdown Data by Type
4.1 Global Age-Related Hearing Loss Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Age-Related Hearing Loss Forecasted 麻豆原创 Size by Type (2024-2029)
5 Age-Related Hearing Loss Breakdown Data by Application
5.1 Global Age-Related Hearing Loss Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Age-Related Hearing Loss Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Age-Related Hearing Loss 麻豆原创 Size (2018-2029)
6.2 North America Age-Related Hearing Loss 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Age-Related Hearing Loss 麻豆原创 Size by Country (2018-2023)
6.4 North America Age-Related Hearing Loss 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age-Related Hearing Loss 麻豆原创 Size (2018-2029)
7.2 Europe Age-Related Hearing Loss 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Age-Related Hearing Loss 麻豆原创 Size by Country (2018-2023)
7.4 Europe Age-Related Hearing Loss 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age-Related Hearing Loss 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Age-Related Hearing Loss 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Age-Related Hearing Loss 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Age-Related Hearing Loss 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age-Related Hearing Loss 麻豆原创 Size (2018-2029)
9.2 Latin America Age-Related Hearing Loss 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Age-Related Hearing Loss 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Age-Related Hearing Loss 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-Related Hearing Loss 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Age-Related Hearing Loss 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Age-Related Hearing Loss 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Age-Related Hearing Loss 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Bionics
11.1.1 Advanced Bionics Company Detail
11.1.2 Advanced Bionics Business Overview
11.1.3 Advanced Bionics Age-Related Hearing Loss Introduction
11.1.4 Advanced Bionics Revenue in Age-Related Hearing Loss Business (2018-2023)
11.1.5 Advanced Bionics Recent Development
11.2 Cochlear
11.2.1 Cochlear Company Detail
11.2.2 Cochlear Business Overview
11.2.3 Cochlear Age-Related Hearing Loss Introduction
11.2.4 Cochlear Revenue in Age-Related Hearing Loss Business (2018-2023)
11.2.5 Cochlear Recent Development
11.3 MED-EL GmbH
11.3.1 MED-EL GmbH Company Detail
11.3.2 MED-EL GmbH Business Overview
11.3.3 MED-EL GmbH Age-Related Hearing Loss Introduction
11.3.4 MED-EL GmbH Revenue in Age-Related Hearing Loss Business (2018-2023)
11.3.5 MED-EL GmbH Recent Development
11.4 Nurotron Biotechnology
11.4.1 Nurotron Biotechnology Company Detail
11.4.2 Nurotron Biotechnology Business Overview
11.4.3 Nurotron Biotechnology Age-Related Hearing Loss Introduction
11.4.4 Nurotron Biotechnology Revenue in Age-Related Hearing Loss Business (2018-2023)
11.4.5 Nurotron Biotechnology Recent Development
11.5 Oticon Medical
11.5.1 Oticon Medical Company Detail
11.5.2 Oticon Medical Business Overview
11.5.3 Oticon Medical Age-Related Hearing Loss Introduction
11.5.4 Oticon Medical Revenue in Age-Related Hearing Loss Business (2018-2023)
11.5.5 Oticon Medical Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Age-Related Hearing Loss Introduction
11.6.4 Medtronic Revenue in Age-Related Hearing Loss Business (2018-2023)
11.6.5 Medtronic Recent Development
11.7 Envoy Medical
11.7.1 Envoy Medical Company Detail
11.7.2 Envoy Medical Business Overview
11.7.3 Envoy Medical Age-Related Hearing Loss Introduction
11.7.4 Envoy Medical Revenue in Age-Related Hearing Loss Business (2018-2023)
11.7.5 Envoy Medical Recent Development
11.8 Sonova
11.8.1 Sonova Company Detail
11.8.2 Sonova Business Overview
11.8.3 Sonova Age-Related Hearing Loss Introduction
11.8.4 Sonova Revenue in Age-Related Hearing Loss Business (2018-2023)
11.8.5 Sonova Recent Development
11.9 Audina Hearing Instruments
11.9.1 Audina Hearing Instruments Company Detail
11.9.2 Audina Hearing Instruments Business Overview
11.9.3 Audina Hearing Instruments Age-Related Hearing Loss Introduction
11.9.4 Audina Hearing Instruments Revenue in Age-Related Hearing Loss Business (2018-2023)
11.9.5 Audina Hearing Instruments Recent Development
11.10 RION
11.10.1 RION Company Detail
11.10.2 RION Business Overview
11.10.3 RION Age-Related Hearing Loss Introduction
11.10.4 RION Revenue in Age-Related Hearing Loss Business (2018-2023)
11.10.5 RION Recent Development
11.11 Decibel Therapeutics
11.11.1 Decibel Therapeutics Company Detail
11.11.2 Decibel Therapeutics Business Overview
11.11.3 Decibel Therapeutics Age-Related Hearing Loss Introduction
11.11.4 Decibel Therapeutics Revenue in Age-Related Hearing Loss Business (2018-2023)
11.11.5 Decibel Therapeutics Recent Development
11.12 Frequency Therapeutics
11.12.1 Frequency Therapeutics Company Detail
11.12.2 Frequency Therapeutics Business Overview
11.12.3 Frequency Therapeutics Age-Related Hearing Loss Introduction
11.12.4 Frequency Therapeutics Revenue in Age-Related Hearing Loss Business (2018-2023)
11.12.5 Frequency Therapeutics Recent Development
11.13 Pipeline Therapeutics
11.13.1 Pipeline Therapeutics Company Detail
11.13.2 Pipeline Therapeutics Business Overview
11.13.3 Pipeline Therapeutics Age-Related Hearing Loss Introduction
11.13.4 Pipeline Therapeutics Revenue in Age-Related Hearing Loss Business (2018-2023)
11.13.5 Pipeline Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Advanced Bionics
Cochlear
MED-EL GmbH
Nurotron Biotechnology
Oticon Medical
Medtronic
Envoy Medical
Sonova
Audina Hearing Instruments
RION
Decibel Therapeutics
Frequency Therapeutics
Pipeline Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.